Primary objectives:

1. To evaluate the efficacy of different therapeutic approaches in patients with lymphomatoid granulomatosis

Secondary objectives:

1. To evaluate the toxicity of different therapeutic approaches in patients with lymphomatoid granulomatosis
2. To determine the patient and disease characteristics in this patient population
3. To identify prognostic factors

20 July 2023 – umbrella lymphoma ethics been approved. CRF to be circulated

17 February 25 – being revitalised, ethics being reworked. Hope to circulate protocol within next few months

29 July 2025 – had experienced delays with ethics, good to go now. Welcome interest. Once ready locally, will reach out.

19 February 2026 – in development and moving forward.

1 June 2026 – ethics has now been sorted. Protocol has been written, will circulate shortly

17 Sept 2026 – protocol will be circulated with a plan to move forward